BBH holdings and overlap
VanEck Biotech ETF (BBH) holds 24 positions in its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26. Its three largest are Amgen (AMGN) at 15.25%, Gilead Sciences (GILD) at 12.79% and Vertex Pharmaceuticals (VRTX) at 9.10%, and its ten largest make up 70.3% of the fund.
In its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26, BBH is 100.0% health care by sector, with none of it in mega-cap tech or in the ten largest US companies by market value. By country, 90.1% of BBH is in the United States, 5.0% in Belgium, 1.9% in Germany and 1.9% in Ireland.
What does BBH hold, from its SEC Form N-PORT for the period ended 2026-06-30?
Amgen is 15.25% of BBH on its own, against a median largest position of 8.7% across the 28 Health Care funds with a page here. The position BBH carries furthest above that group is Gilead Sciences at 12.79% of the fund, against a 1.63% median there.
| Rank | Company | Weight | Weight bar |
|---|---|---|---|
| 1 | AMGN Amgen | 15.25% | |
| 2 | GILD Gilead Sciences | 12.79% | |
| 3 | VRTX Vertex Pharmaceuticals | 9.1% | |
| 4 | REGN Regeneron Pharmaceuticals | 6.21% | |
| 5 | RVMD Revolution Medicines | 5.27% | |
| 6 | ARGX Argenx SE | 4.97% | |
| 7 | NTRA Natera | 4.92% | |
| 8 | IQV IQVIA | 4.31% | |
| 9 | ALNY Alnylam Pharmaceuticals | 3.83% | |
| 10 | BIIB Biogen | 3.63% | |
| 11 | MRNA Moderna | 3.36% | |
| 12 | ILMN Illumina | 3.17% | |
| 13 | UTHR United Therapeutics Corporation | 2.83% | |
| 14 | ONC BeOne Medicines Ltd | 2.81% | |
| 15 | INSM Insmed | 2.67% | |
| 16 | INCY Incyte | 2.49% | |
| 17 | NBIX Neurocrine Biosciences | 2.08% | |
| 18 | BNTX BioNTech SE | 1.94% | |
| 19 | ICLR ICON | 1.9% | |
| 20 | TECH Bio-Techne | 1.54% | |
| 21 | CRL Charles River Laboratories | 1.5% | |
| 22 | BMRN BioMarin Pharmaceutical | 1.34% | |
| 23 | QGEN Qiagen | 1.06% | |
| 24 | TEM Tempus AI | 0.98% |
BBH's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26; a newer filing replaces it when the nightly read of EDGAR finds one. Every one of the 24 positions BBH holds, with its weight, is in the fund's JSON file. See the other 126 ETFs with a page here that hold AMGN, and how their weights compare with the 15.25% BBH gives it.
Category: Health Care, set by TickerInside from the ETF's own latest file. In its file of 2026-06-30, 100% of its stocks whose sector is known are health care companies, each in the sector the site gives that company. How categories are set.
https://tickerinside.com/api/v1/fund/bbh.jsonhttps://tickerinside.com/api/v1/fund/bbh.csv=IMPORTDATA("https://tickerinside.com/api/v1/fund/bbh.csv")If your sheet uses a decimal comma: =IMPORTDATA("https://tickerinside.com/api/v1/fund/bbh.csv"; ","; "en_US")curl -s https://tickerinside.com/api/v1/fund/bbh.jsonHow is BBH split by sector and country?
| Sector | Weight | Weight bar |
|---|---|---|
| Health care | 100.0% |
| Country | Weight | Weight bar |
|---|---|---|
| United States | 90.1% | |
| Belgium | 5.0% | |
| Germany | 1.9% | |
| Ireland | 1.9% | |
| Netherlands | 1.1% |
From its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26. How these are measured.
What did BBH hold in its SEC reports since 2019?
BBH's largest position in its SEC filings has been Amgen (AMGN) since 2019-09-30: 10.74% then and 15.25% in its report for 2026-06-30, across 28 quarterly reports.
| Report | Positions | Largest | Top 10 |
|---|---|---|---|
| 2019-09-30 | 24 | AMGN 10.74% | 59.2% |
| 2019-12-31 | 23 | AMGN 12.18% | 57.8% |
| 2020-12-31 | 23 | AMGN 12.89% | 59.4% |
| 2021-12-31 | 25 | AMGN 11.43% | 63.5% |
| 2022-12-31 | 25 | AMGN 12.18% | 62.0% |
| 2023-12-31 | 23 | AMGN 17.52% | 74.2% |
| 2024-12-31 | 25 | AMGN 15.51% | 70.3% |
| 2025-12-31 | 25 | AMGN 15.09% | 71.6% |
| 2026-06-30 | 24 | AMGN 15.25% | 70.3% |
The first report, then the last of each year, of the 28 reports BBH filed on SEC Form N-PORT from 2019-09-30 to 2026-06-30, each company under its ticker today. Every position of every report is in its quarterly file, and at any date at /api/v1/history/bbh/{date}.json. How these are read.
What does BBH duplicate?
The ETF nearest to BBH is IBB: the two hold 62.4% of their weight in common, in the 21 companies both own, and 92.7% of BBH itself is also held there. Owning BBH alongside the ETFs at the top of this table means about half of the weight is held twice.
| ETF | Overlap by weight | Of BBH held there | Of that ETF in BBH | Companies in both | Overlap bar |
|---|---|---|---|---|---|
| IBB | 62.4% | 92.7% | 65.3% | 21 | |
| IBBQ | 53.2% | 84.8% | 56.1% | 18 | |
| PBE | 44.3% | 68.3% | 53.8% | 13 | |
| FBT | 41.0% | 78.9% | 47.9% | 16 | |
| BMED | 31.1% | 67.8% | 35.6% | 13 | |
| GNOM | 22.5% | 39.2% | 40.9% | 9 | |
| XBI | 22.0% | 75.8% | 22.0% | 14 | |
| PJP | 20.5% | 40.7% | 21.0% | 5 | |
| RSPH | 18.9% | 63.4% | 19.1% | 11 | |
| IDNA | 18.0% | 28.4% | 30.1% | 6 | |
| IYH | 16.6% | 88.4% | 16.6% | 20 | |
| QQQJ | 14.7% | 34.2% | 14.7% | 11 |
BBH's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26. FBT's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21. The other ETFs' holdings are from their issuers' latest files. Check BBH against any ETF in the ETF overlap calculator · how overlap is measured.
What adds something different to BBH?
IJR shares 0% of weight with BBH. The table lists the covered ETFs with the least in common with BBH, least shared weight first.
| ETF | Name | Overlap by weight | Companies in both |
|---|---|---|---|
| IJR | iShares Core S&P Small-Cap ETF | 0.0% | 0 |
| SOXX | iShares Semiconductor ETF | 0.0% | 0 |
| SCZ | iShares MSCI EAFE Small-Cap ETF | 0.0% | 0 |
| PFF | iShares Preferred and Income Securities ETF | 0.0% | 0 |
| MCHI | iShares MSCI China ETF | 0.0% | 0 |
| REET | iShares Global REIT ETF | 0.0% | 0 |
| USRT | iShares Core U.S. REIT ETF | 0.0% | 0 |
| IYR | iShares U.S. Real Estate ETF | 0.0% | 0 |
BBH's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26. The other ETFs' holdings are from their issuers' latest files.
Cost and concentration
| Expense ratio | 0.35% |
|---|---|
| Weight in the ten largest positions | 70.3% |
| Largest single position | 15.2% |
The expense ratio is reference data, from BBH's SEC filing of 2026-01-27; the weights are from BBH's SEC Form N-PORT for the period ended 2026-06-30.
Where to go next
- BMED, iShares Health Innovation Active ETF
- CANC, Tema Oncology ETF
- FBT, First Trust NYSE Arca Biotechnology Index Fund
- FMED, Fidelity Disruptive Medicine ETF
- Run a portfolio x-ray to see what BBH carries once you look through it
- Compare BBH against any other ETF in the builder
Holdings from BBH's SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26. How every figure here is produced. Measurements, not investment advice.
Cite this page
TickerInside, VanEck Biotech ETF (BBH), holdings from SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26, https://tickerinside.com/etf/bbh/, CC BY 4.0
<a href="https://tickerinside.com/etf/bbh/">TickerInside</a> (https://tickerinside.com/etf/bbh/)